Headquartered in Belgium with significant U.S. operations, the company has successfully transitioned into a commercial-stage powerhouse focused on urologic cancers. MDxHealth signed a definitive agreement to acquire the business of Exosome Diagnostics, Inc. for $15 million (August 2025), with $5 million in stock at closing and $2.5 million annually over the following 4 years, and completed the acquisition on September 15, 2025.
Cyborg Score Rationale
The company has a market cap of approximately $39.5 million as of August 2026, with negative earnings (EPS of -0.65). Analysts expect the company to break even for the first time, with consensus forecasts suggesting losses will reduce by 36% per year to 2026. The company is in a critical transition phase toward profitability with expanding commercial capabilities.
Top Insights
Core product portfolio includes Select mdx (non-invasive urine test for prostate cancer), Confirm mdx (tissue test for occult prostate cancer detection), Resolve mdx (personalized antibiotic selection for UTI), and Genomic Prostate Score (personalized genomic insights).
Company reaffirmed full year 2025 revenue guidance of $108 million to $110 million (as of late 2025).
Analysts covering the stock expect the company to achieve first-time profitability and project approximately $2.35 million profit by 2027.
MDxHealth has 312 full-time employees.
Named Competitors
Myriad Genetics — Leading precision diagnostics with oncology focus
CareDx — Molecular diagnostics for organ transplant monitoring
NeoGenomics — Cancer diagnostics and genomic analysis
Labcorp Holdings — Clinical laboratory and molecular diagnostics
Recent Developments
(August 2025) Signed definitive agreement to acquire Exosome Diagnostics business for $15 million
(September 2025) Completed acquisition of Exosome Diagnostics business
(May 2026) William Blair downgraded MDxHealth from Outperform to Market Perform
(May 2026) Q1 2026 earnings release reported
Open the full interactive MDxHealth SA report
Strategic research, analyst-debate audio, full Cyborg Score breakdown across 11 dimensions, and saved-company audio playlists.